PT - JOURNAL ARTICLE AU - Xue, Xiaobo AU - Ma, Jing AU - Zhao, Yuxia AU - Zhao, Aibin AU - Liu, Xiaohong AU - Guo, Wei AU - Yan, Fang AU - Wang, Zhixin AU - Guo, Yanqing AU - Fan, Mengbai TI - Correlation between hypophosphatemia and the severity of Corona Virus Disease 2019 patients AID - 10.1101/2020.03.27.20040816 DP - 2020 Jan 01 TA - medRxiv PG - 2020.03.27.20040816 4099 - http://medrxiv.org/content/early/2020/03/30/2020.03.27.20040816.short 4100 - http://medrxiv.org/content/early/2020/03/30/2020.03.27.20040816.full AB - Objective Retrospectively analyze the clinical data of Corona Virus Disease 2019 (COVID-19) patients and explore the value of serum phosphorus level in evaluating the severity and prognosis of the disease.Methods COVID-19 patients transferred from the first emergency ward of Taiyuan fourth people’s Hospital from February 8 to March 3, 2020 were enrolled. The information of general conditions, clinical manifestations, laboratory indexes, nucleic acid detection and treatment were collected. The changes of blood phosphorus level and absolute value of lymphocytes in ordinary and severe/critical patients were recorded and compared.Results A total of 32 patients with COVID-19 were collected, including 12 cases of common type and 20 cases of severe/critical type. Before treatment, the serum phosphorus levels of the two groups were significantly lower than the normal level, and the serum phosphorus levels of the severe/critical patients were lower than those of the common type patients (t = 2.767, P < 0.010). After treatment, the serum phosphorus levels of the two groups reached normal, and there was no significant difference between the two groups (t = 0.231, P >0.819). The level of lymphocytes in severe/critical patients was lower than that in normal patients (t = 4.636, P < 0.001) before treatment. After treatment, the absolute value of lymphocytes in the two groups reached normal, and there was no significant difference between the two groups (t=1.208,P=0.237). There was a positive correlation between lymphocytes and serum phosphorus, and the correlation coefficient was 0.479.Conclusion hypophosphatemia is related to the severity of COVID-19, and strengthening the monitoring of serum phosphorus level of COVID-19’s severe/critical patients and correcting hypophosphatemia in time are of significance to improve the prognosis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe basic applied research projects in Shanxi Province (grant number 201601D021156); The Scientific Research Fund of Shanxi cardiovascular Hospital (grant number 20170203)Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data used during the study are available.